Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sleep your way to better blood sugar? new study tests behavioral fix for type 1 diabetes

NCT ID NCT07522866

First seen Apr 19, 2026

Summary

This study tests whether a 12-week sleep-focused behavioral program can help adults with type 1 diabetes improve their sleep and blood sugar control. Participants learn sleep hygiene, stress management, and routines to target 7-9 hours of quality sleep. The study tracks sleep with a wrist monitor and glucose with standard devices.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30329, United States

  • Emory University, Nell Hodgson Woodruff School of Nursing

    RECRUITING

    Atlanta, Georgia, 30322, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cognitive behavioral sleep intervention

What this could lead to

If successful, this could point toward a practical, drug-free way to help people with type 1 diabetes improve their blood sugar control through better sleep.

What could go wrong

This is a small early-stage trial with only 48 participants, so results may not apply to everyone. The intervention requires significant lifestyle changes, and not everyone may benefit.

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.